| Literature DB >> 35668506 |
Francesco Baldo1, Laura Morra2, Agnese Feresin2, Flavio Faletra3, Yasmin Al Naber4, Luigi Memo4, Laura Travan5.
Abstract
BACKGROUND: Loeys-Dietz syndrome (LDS) is a rare connective tissue disorder characterized by cardiovascular manifestations, especially aortic dilatations and arterial tortuosity, craniofacial and skeletal features, joint laxity or contractures, skin abnormalities, hypotonia and motor delay. Its diagnosis is established by the identification of a pathogenic variant in TGFBR1, TGFBR2, SMAD2, SMAD3, TGFB2 or TGFB3 genes. In newborns and toddlers, vascular complications such as aneurism rupture, aortic dissection, and intracerebral incidents, can occur already in the weeks of life. To avoid these events, it is crucial to precociously identify this condition and to start an apunderwent a surgical procedurepropriate treatment which, depending on the severity of the vascular involvement, might be medical or surgical. CASEEntities:
Keywords: Aneurysm; Connective tissue disorder; Loeys-Dietz syndrome; Newborn
Mesh:
Substances:
Year: 2022 PMID: 35668506 PMCID: PMC9169291 DOI: 10.1186/s13052-022-01281-y
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 3.288
Surgical recommendations in Loeys-Dietz syndrome (from Williams et al., modified) [19]
| Children | Adults | |
|---|---|---|
| Severe craniofacial features | Mild craniofacial features | |
1) Aortic root z-score > 3 or rapidly expanding (0.5 cm over 1 year) | 1) Aortic root z-score > 4 or rapidly expanding (0.5 cm over 1 year) | 1) Aortic root z-score > 4 or rapidly expanding (0.5 cm over 1 year) |
| 2) Effort made to delay surgery until the annulus reaches 1.8 cm, allowing placement of a valve sparing graft to sufficient size to accommodate growth | 2) Large size or rapid expansion of the descending aorta or other vessels | 2) Descending thoracic aorta > 5 cm or rapidly expanding (0.5 cm over 1 year) |
| 3) Abdominal aorta > 4 cm or rapidly expanding (0.5 cm over 1 year) | ||
| 4) Rapid expansion of peripheral aneurysm | ||
Fig. 1Patient 1: axial hypotonia
Fig. 2Patient 1: senile appearance
Fig. 3Patient 1: lax skin
Fig. 4Patient 2: overall appearance
Genetic variants, time of appearance of vascular abnormalities and original diagnostic suspect in the 16 patients identified with early diagnosis of Loeys Dietz syndrome
| Report | Variant | Appearance of vascular abnormalities | Original diagnostic suspect |
|---|---|---|---|
| Choo JTL et al | 1583G > A(R528H), exon 7, TGFBR2 | 2 months | Arthrogryposis |
| Ilyn VN et al | / | Prenatal ultrasound | / |
| Muramatsu Y et al | c.1370 T > A(M457L), exon 5, TGFBR2 | 1 month | / |
| Kuppler KM et al | 1583G > A (R528H), exon 7, TGFBR2 | 3 months | / |
| Wisniewski K et al | / | 1 month | / |
| Valenzuela I et al | c.1381 T > C, TGFBR2 | 1 month | Arthrogryposis |
| Ozawa H et al.; Kawazu Y et al | 598A > C, TGFBR1 | Prenatal ultrasound (36 weeks) | / |
| Viassolo V et al | TGFBR2 | Prenatal ultrasound (19 weeks) | / |
| Yetman AT et al. [ | 1583G > A, exon 7, TGFBR2 | 1 month | Beals syndrome, Larsen syndrome, arthrogryposis |
| Yetman AT et al. [ | 1570G > A, exon 7, TGFBR2 | 1 month | Larsen syndrome |
| Yetman AT et al. [ | 1318G > A, exon 5, TGFBR2 | 9 years | Larsen syndrome |
| Yetman AT et al. [ | 865-873delACAGAGAAG, exon 4, TGFBR2 | 1 month | Arthrogryposis, Larsen syndrome |
| Yetman AT et al. [ | IVS5-1G > A (splicing variant), TGFBR2 | 6 months | Beals syndrome |
| Chung BHY et al | 1583G > A(R528H), exon 7, TGFBR2 | 1 month | / |
| Patient 1 | c.1378C > G, p (Arg460Gly), exon 5, TGFBR2 | 1 month | Loeys Dietz |
| Patient 2 | c899G > A, p (Arg300Gin), TGFB3 | / | / |
Phenotypic description of the patients. “Cardio” indicates any structural abnormality of the heart, such as septal defects or cardiomegaly. “Neuro” includes any neurological abnormality on physical examination, such as hypotonia. “Skeletal” includes any bone or joints alterations (including arachnodactyly) apart from spine involvement, which is reported as “spine”. Head includes dysmorphic features of the patient’s face, with the exclusion of micrognathia (“micrognathia”) and cleft palate (“uvula/palate”)
| Author | Aorta | Pulmonary | Tortuosity | Cardio | Skeletal | Eyes | Head | Uvula/Palate | Micrognathia | Spine | Hernias | Feet | Neuro |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Choo JTL et al | Yes | Yes | / | Yes | Yes | Yes | Yes | Yes | Yes | / | / | / | Yes |
| Ilyn VN et al | Yes | / | Yes | Yes | / | Yes | / | Yes | / | / | / | / | / |
| Muramatsu Y et al | Yes | Yes | Yes | Yes | Yes | Yes | / | Yes | Yes | / | Yes | Yes | Yes |
| Kuppler KM et al | Yes | Yes | / | / | Yes | Yes | / | Yes | / | / | / | Yes | / |
| Wisniewski K et al | Yes | Yes | Yes | Yes | Yes | Yes | / | Yes | Yes | / | Yes | / | / |
| Valenzuela I et al | Yes | / | Yes | / | Yes | Yes | / | Yes | / | / | Yes | Yes | / |
| Ozawa H et al | Yes | Yes | Yes | Yes | Yes | / | / | Yes | / | / | / | / | / |
| Viassolo V et al | Yes | / | / | / | Yes | Yes | Yes | Yes | Yes | / | / | Yes | / |
| Yetman AT et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | / | Yes | Yes | Yes | Yes |
| Yetman AT et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | / | Yes | Yes | Yes | Yes |
| Yetman AT et al. [ | Yes | / | Yes | / | Yes | Yes | Yes | Yes | / | Yes | Yes | Yes | Yes |
| Yetman AT et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | / | Yes | Yes | Yes | Yes | |
| Yetman AT et al. [ | Yes | / | / | / | Yes | Yes | Yes | Yes | / | Yes | Yes | Yes | Yes |
| Chung BHY et al | Yes | Yes | Yes | / | Yes | / | / | / | Yes | Yes | Yes | Yes | / |
| Patient 1 | Yes | / | / | Yes | Yes | Yes | Yes | / | Yes | / | / | / | Yes |
| Patient 2 | / | / | / | / | Yes | Yes | Yes | Yes | Yes | / | / | / | / |
Therapeutic management. ARB: angiotensin II receptor blocker (losartan). PDA: patent ductus arteriosus. ASD: atrial sept defect. VSD: ventricular sept defect. NR: not reported
| Report | Medical therapy | Surgery | Surgical treatment | Surgical timing (age) |
|---|---|---|---|---|
| Choo JTL et al | / | No | / | / |
| Ilyn VN et al | Beta-blocker | Yes | Aneurism resection, repair of aortic coarctation, subclavian ligation | 1 year |
| Muramatsu Y et al | ACE-inhibitor | Yes | Pulmonary artery banding - ASD and VSD closure, pulmonary artery plastic | 12 days - 42 days |
| Kuppler KM et al | / | No | / | / |
| Wisniewski K et al | Beta-blocker, ARB | Yes | PDA closure - Valve sparing aortic root replacement | 40 days - 8 months |
| Valenzuela I et al | Beta-blocker, ARB | No | / | / |
| Ozawa H et al | ARB | Yes | Bilateral pulmonary artery banding | 9 days (urgent) |
| Viassolo V et al | / | No | / | / |
| Yetman AT et al. [ | Beta-blocker, ACE-inhibitor | No | / | / |
| Yetman AT et al. [ | ACE-inhibitor | Yes | PDA ligation | NR |
| Yetman AT et al. [ | / | Yes | Aortic valve replacement, aortic replacement | 9 years |
| Yetman AT et al. [ | ACE-inhibitor | Yes | Valve sparing surgery | 2 years |
| Yetman AT et al. [ | / | Yes | Valve sparing surgery | 3 years |
| Chung BHY et al | ARB | No | / | / |
| Patient 1 | ARB | No | / | / |
| Patient 2 | / | No | / | / |